Valeo Financial Advisors, LLC: VSS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Valeo Financial Advisors, LLC on VSS, newest first. How the timeline and the estimate are built.
Valeo Financial Advisors, LLC held 3,306 VSS shares at 2026-09-30 per its 13F-HR filed 2026-10-08.
the latest 13F is the newest step
- period ended2026-09-3013F 3,306 sharesChange vs previous 13F +2 shares
0.01% of the 13F portfolio, value $513,322.
13F-HR 0001722641-26-000006 filed by Valeo Financial Advisors, LLC
Accepted , ingested - period ended2026-06-3013F 3,304 sharesChange vs previous 13F +7 shares
0.01% of the 13F portfolio, value $509,789.
13F-HR 0001722641-26-000004 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 3,297 sharesChange vs previous 13F 0 shares
0.01% of the 13F portfolio, value $480,717.
13F-HR 0001722641-26-000003 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 3,297 sharesChange vs previous 13F +63 shares
0.01% of the 13F portfolio, value $472,605.
13F-HR 0001722641-26-000001 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 3,234 sharesChange vs previous 13F -287 shares
0.01% of the 13F portfolio, value $460,968.
13F-HR 0001722641-25-000007 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F/A 3,521 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $473,227.
13F-HR/A 0001722641-25-000005 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).